Status:
UNKNOWN
Gastrointestinal And Metabolic Effects From a Prebiotic, Lifting, and Aerobic iNtervention
Lead Sponsor:
University of Illinois at Urbana-Champaign
Conditions:
Overweight and Obesity
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
This study aims to determine the independent and combined effects of prebiotic fiber supplementation and exercise on the gut microbiome and human health.
Eligibility Criteria
Inclusion
- BMI 18.5-45 kg/m2
- Without physician diagnosed gastrointestinal or metabolic diseases
- Sedentary (\< 30 minutes of moderate or high intensity exercise per week OR \< 20 aggregate Godin-Shepard Leisure Time Physical Activity Questionnaire (GSLTQ; GodinLeisure) score)
- Fully vaccinated against COVID-19
Exclusion
- Fasting blood glucose \>126 mg/dL
- Blood pressure \>160/100 mm Hg
- Physician diagnosed metabolic or gastrointestinal diseases or constipation
- Heart conditions that may pose risk during exercise
- Taking oral hypoglycemic agents or insulin
- Pregnant, breastfeeding or postmenopausal
- Smoke or consume \> 2 alcoholic beverages/day, abuse drugs
- Have had \> 5% weight change in the past month or \> 10% change in the past year
- Have had any form of bariatric surgery or gallbladder removal
- Have taken antibiotics during the previous 3 months
- Unable to consume the experimental fiber
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05207488
Start Date
October 1 2021
End Date
September 20 2023
Last Update
November 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Urbana-Champaign
Urbana, Illinois, United States, 61801